Archview - you've been regurgitating the same rubbish for the past 3 months. Appreciate your insights but your slandering of the board is starting to fall on deaf ears.
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025